Zepp Health (NYSE:ZEPP) Given a $13.87 Price Target at Fundamental Research

Zepp Health (NYSE:ZEPP) has been given a $13.87 target price by investment analysts at Fundamental Research in a note issued to investors on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock. Fundamental Research’s price target would suggest a potential upside of 351.06% from the company’s current price.

Zepp Health Stock Performance

Shares of Zepp Health stock opened at $3.08 on Tuesday. Zepp Health has a 52 week low of $2.06 and a 52 week high of $4.38. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.87 and a current ratio of 1.21. The stock has a market capitalization of $46.28 million, a price-to-earnings ratio of -1.23 and a beta of 0.75. The firm has a fifty day moving average of $2.98 and a two-hundred day moving average of $3.09.

Hedge Funds Weigh In On Zepp Health

A hedge fund recently bought a new stake in Zepp Health stock. Mandatum Life Insurance Co Ltd purchased a new stake in Zepp Health Co. (NYSE:ZEPP) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 10,750 shares of the company’s stock, valued at approximately $28,000. Mandatum Life Insurance Co Ltd owned 0.07% of Zepp Health at the end of the most recent reporting period. 52.61% of the stock is owned by institutional investors and hedge funds.

Zepp Health Company Profile

Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company operates in two segments: Self-Branded Products and Others, and Xiaomi Wearable Products. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.